KAPA
Kairos Pharma
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About KAPA
Kairos Pharma, Ltd.
A small California-based biotechnology company focused on cancer
2355 Westwood Blvd., #139, Los Angeles CA 90064
--
Kairos Pharma, Ltd., was incorporated under the laws of the State of California on June 17, 2013 under the name NanoGB 13, Inc., and subsequently converted to a Delaware corporation on May 10, 2023 under the name Kairos Pharma, Ltd. The company is a clinical-stage biopharmaceutical company dedicated to the treatment of cancer patients, aiming to overcome key barriers in immunosuppression and drug resistance. These therapies include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer and glioblastoma.
Company Financials
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
